NSNatalia V. Sharova

Natalia V. Sharova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalia V. Sharova has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The significance of positional changes in spirometric parameters in unilateral diaphragm dysfunction

    by N.V. Sharova, D.V. Cherkashin, A.D. Sobolev, S.V. Efimov, I.M. Zakharova, K.N. Tkachenko

    Aim. To evaluate the diagnostic significance of positional changes in the vital capacity of the lungs (ΔVC) and forced vital capacity of the lungs (ΔFVC) in the verification of unilateral diaphragm dysfunction, confirmed by radiographic data and ultrasound examination results. Design. Comparative observational prospective study Materials and methods. The study was conducted at the Naval Therapy Clinic of the S.M. Kirov Military Medical Academy from March 2021 to January 2025. The study group consisted of 44 patients with medical conditions complicated by unilateral diaphragmatic dysfunction: 12 with complete diaphragmatic dysfunction and 32 with partial diaphragmatic dysfunction. The control group included 20 patients with comparable conditions and no signs of respiratory muscle damage. According to the developed algorithm, all participants underwent a comprehensive examination, including chest X-ray and computed tomography, diaphragm ultrasound, and spirometry. Baseline lung volumes and their positional changes were assessed: ΔVC (%), ΔFVC (%), and forced expiratory volume in the first second (ΔFEV1, %). Results. In case of complete diaphragm dysfunction, a decrease in VCF to 66.0 [58.6; 85.9] % (FVC to 73.5 [63.4; 87.3] %) and a positional decrease in ΔVC% by –16.5 [–25.1; –9.4] % (ΔFVC% by –11.0 [–25.4; –6.3] %) were detected. In case of partial diaphragm dysfunction, the figures were statistically significantly higher: VCF was 80.5 [75.5; 91.2] % (FVC — 76.0 [72.0; 88.4] %) and a positional decrease in ΔVC% by –5.0 [–9.5; –0.4] % (ΔFVC% by –9.7 [–13.0; –5.6] %). In 12 patients with unilateral complete dysfunction, ultrasound examination revealed a combined decrease in diaphragmatic excursion and fractional thickening to 17.0% on the affected side. A statistically significant negative correlation of moderate strength (p = 0.028 and p = 0.04) was established between ΔVC (ΔFVC) and fractional thickening, confirming the involvement of the diaphragm in the genesis of positional changes. The results of dynamic observation indicate the feasibility of individualized assessment of spirometric and positional parameters (ΔVC, ΔFVC, ΔFEV1) for monitoring the functional status of these patients. Conclusion. A positional decrease in the indicators by more than 15%, combined with a decrease in baseline VC and FVC values, can be considered as a diagnostic criterion for unilateral complete diaphragmatic dysfunction. Furthermore, identifying a group of patients with partial diaphragmatic dysfunction allows for a more precise characterization of functional impairment, even in mild cases. In cases where the positional decrease in ΔVC and ΔFVC ranges from 10 to 15%, confirmation of the diagnosis by ultrasound is mandatory. A comprehensive assessment of positional changes in lung volumes and ΔVC and ΔFVC indicators is useful for monitoring the functional status of patients with unilateral diaphragmatic dysfunction during treatment and follow-up. Keywords: unilateral complete dysfunction of the diaphragm, unilateral partial dysfunction of the diaphragm, positional changes, ΔVC, ΔFVC, fractional thickening of the diaphragm.

  • Open Access

    The Possibilities of Diagnosing Diaphragm Dysfunction in the Practice of a Therapist

    by Military Medical Academy Named After S.M. Kirov, N.V. Sharova, D.V. Cherkashin, Russian Federation Military Medical Academy Named After S.M. Kirov; Saint Petersburg, R.G. Makiev, E.I. Sukhoroslova, A.D. Sobolev, K.P. Raevsky

    Aim. To show the diagnostic possibilities of detecting diaphragm dysfunction (DD) in the practice of a therapist using a complex of non-invasive studies, including clinical, radiological, spirometric, ultrasound and neurophysiological techniques. Design. An open cohort study. Materials and methods. 28 patients with DD were examined: 6 with complete DD (DDc) and 22 with partial DD (DDp). The complex of non-invasive studies for suspected DD included clinical, radiological (chest X-ray while standing and lying down, with calm and forced breathing; video recording of the diaphragm during breathing; spiral computed tomography of the chest), spirometric (sitting and lying down), ultrasound and neurophysiological studies. Results. Clinical features of dyspnea (associated with physical exertion, occurrence during lying down, swimming, in combination with comorbid diseases), the presence of a thoracoabdominal paradox, characteristic radiological (high standing of the dome of the diaphragm with decreased mobility, paradoxical movement and a positive Sniff test), spirometric (initial dose was 72 to 48% with a decrease of 20.83 ± 18.49% during the transition to the supine position), ultrasound disorders (decreased excursion of patients with the affected half of the diaphragm and the fraction of thickening of the diaphragm on deep inspiration and Sniff test). DDp was diagnosed in 22 patients, and the results of X-ray examination (with an emphasis on video recording of the respiratory cycle) were crucial. In 12 patients, the diagnosis was confirmed by the results of spirometric and ultrasound examinations. Conclusion. Nonspecific clinical manifestations of DD in combination with comorbid diseases with insufficient knowledge and lack of alertness on the part of the doctor determine its underdiagnosis in real practice. Suspicion of the development of DD should arise in the presence of certain features of dyspnea, a combination of DD with previous procedures (surgical interventions) near the diaphragmatic nerve, and the inability to explain the origin of dyspnea by the most common pathology. The use of a full range of noninvasive studies in the therapist's practice made it possible to identify DDc (in the form of complete hemidiaphragmal paresis) in 6 patients (with evidence at each stage of the examination). DDp was proven in 22 patients based on the results of X-ray (with an emphasis on video recording of the respiratory cycle) and ultrasound examinations in 12 patients. Keywords: dysfunction of the diaphragm, shortness of breath, X-ray and ultrasound examination of the diaphragm, spirometry.

  • Open Access

    The Choice of an Inhalation Device Based on Peak Inspiratory Flow Value in Patients with Bronchial Asthma

    by N.V. Sharova, Russian Federation Saint Petersburg, D.V. Cherkashin, Russian Federation S.M. Kirov Military Medical Academy; Saint Petersburg, R.G. Makiev, A.D. Sobolev, A.I. Zakharova, N.N. Shcherbina

    Aim. To determine the value of peak inspiratory flow (PIF) in patients depending on the level of control and the period of bronchial asthma (BA) in order to choose the preferred inhaler with an emphasis on the turbuhaler. Design. Cohort, comparative, prospective study. Materials and methods. 71 patients with BA were examined. The patients were divided into three groups: 20 patients with complete BA control, 23 patients with partial BA control, and 28 patients with exacerbation of the disease. The control group consisted of 29 healthy men. When determining the PIF, a metered aerosol inhaler and a respimat (R0, without resistance) were taken into account, as well as five levels of resistance for powder inhalers (PI), each corresponding to a specific type of inhaler: R1 — low (breezhaler, aerolizer), R2 — medium-low (ellipta), R3 — medium (turbuhaler, spiromax), R4 — medium-high (nexthaler), and R5 — high resistance (handihaler). Optimal PIF values were considered to be R0 ≥ 90 l/min, R1–R4 ≥ 60 l/min, R5 ≥ 30 l/min, with lower values being suboptimal (sPIF), and PIF 30 l/min for R1–R4 being minimal. 64 patients received formoterol/budesonide using various delivery devices, and 24 of them used the turbuhaler inhalation device. Results. The determination of PIF when simulating the resistance of an inhalation device revealed sPIF in 5–45% of patients with complete control of asthma (using a turbuhaler — 20%, in practice, sPIF was not detected). In patients with partial control of asthma, sPIF was observed in 13–56% of patients (using a turbuhaler — 35%, in practice, this figure was 80% among patients receiving formoterol/budesonide). In patients with exacerbations of BA, the limitation of PIF was observed in 11–86% of patients (in 68% of patients using the turbuhaler, and in 100% of patients taking formoterol/budesonide). Conclusion. In the case of complete control of asthma, with an imitation value of sPIF in 20% and no sPIF in practice, most patients were able to use drug delivery devices according to their preferences, provided that the inhalation technique was correct. In the case of partial control of asthma, the proportion of imitation sPIF increased. Optimization of inhalation therapy using the turbuhaler involved increasing the dose of medication. All patients with exacerbations of asthma were prescribed nebulizer therapy and metered-dose inhalers with a spacer upon admission to the hospital. The imitation limitation of PIF was observed with all types of PIs indicating the ineffectiveness of using the turbuhaler during this period of the disease. Temporary change of the PI with medium resistance of the device (turbuhaler) to the metered aerosol inhaler (rapihaler with spacer) with zero resistance, it allows for a personalized approach to choosing an inhaler at the time of hospitalization for patients with exacerbated BA, upon discharge, and by the 30th day of follow-up. Keywords: bronchial asthma, inhaler, turbuhaler, rapihaler, peak inspiratory flow

  • Open Access

    Optimization of Inhalation Therapy Considering Peak Inspiratory Flow in Patients with Exacerbation of Chronic Obstructive Pulmonary Disease in Real Clinical Practice

    by Military Medical Academy Named After S.M. Kirov, N.V. Sharova, D.V. Cherkashin, Russian Federation Military Medical Academy Named After S.M. Kirov; St. Petersburg, A.D. Sobolev, R.G. Makiev, S.A. Parcernjak, B.A. Jerdneev

    Aim: To determine the values of peak inspiratory flow (PIP) for choosing an inhaler in patients with exacerbation of chronic obstructive pulmonary disease (COPD) and to evaluate the possibility of optimizing inhalation therapy considering PIP in real clinical practice. Design: Open cohort controlled prospective study. Materials and methods. 76 people were examined. Group 1 included 32 patients with COPD exacerbation, 18 of them were re-examined before discharge and completed a survey 3 months after discharge from the hospital. Group 2 consisted of 15 patients with stable COPD. Group 3 included 29 healthy individuals. PIF using various inhalers was studied using the In-Check DIALTM G16 Clement Clarke International Limited (Great Britain), fixing the level without resistance (R0) and 5 levels of resistance (R1–R5). Suboptimal PIF (sPIF) values were considered at R0 < 90, R1–R4 < 60, R5 < 30 l/min. Spirometry was performed on a Flowscreen II spirometer (Jaeger) with a flow-volume curve recording, calculation of generally accepted indicators, and on a PTS-14P-01 pressure-tachospirograph to determine the peak inspiratory rate. Statistical data processing was carried out using the Statistica v. 10. According to the Bonferroni principle, differences were considered significant at p < 0.005. Results. During exacerbation of COPD, a decrease in PIF from 120 to 40 l/min (p < 0.001 compared with the control) and the presence of sPIF in 5–75% of cases, depending on the type of inhalation device, were revealed (no sPIF was noted in the control). Most patients were free to use a nebulizer, a metered-dose aerosol inhaler (MAI), a liquid inhaler (Respimat) and a breathhaler upon admission to the hospital. Patients could not create the necessary inspiratory effort when using the ellipt in 47% of cases, turbuhaler — in 63%, nexthaler — in 75%, handihaler — in 31%. With proven positive clinical and functional dynamics during treatment (increase in FEV1 from 37% (28; 53) to 55% (37; 62), p < 0.004), the identified changes persisted by the time of discharge from the hospital and did not reach the values of PIF and sPIF, determined in stable COPD. Analysis of PIF and sPIF in patients in real clinical practice, depending on the drugs received, showed that by the time they were discharged from the hospital, half of the patients had sPIF, continued to use turbuhaler and handihaler inhalers, and were not able to create an adequate PIF for effective inhalation of drugs. A survey of patients 3 months after discharge from the hospital showed that patients with optimal PIF values, who used drugs with the help of PPI, Respimat and Breezhaler, did not have exacerbations within the indicated periods. Patients with CPIP who continued to use the combination of turbuhaler and handihaler had moderate exacerbations. Conclusion. Optimization of inhalation therapy based on PIP in patients with COPD exacerbation should include: 1) the possibility of choosing the optimal inhaler, considering the direct determination of PIF; 2) replacement of a high-resistance powder inhaler with a PDI/Respimat or a low-resistance powder inhaler (breather, ellipta); 3) education of COPD patients in the correct technique of inhalation. PIF testing in COPD exacerbations may help clinicians identify patients at higher risk of readmission and personalize powder inhaler selection. Keywords: chronic obstructive pulmonary disease, peak inspiratory flow, inhalation therapy, inhaler resistance.


  • Open Access

    Features and significance of the early bronchodilatation effect of the first dose of a long-acting bronchodilator alone and in fixed combination in the treatment of chronic obstructive pulmonary disease

    by Natalia V. Sharova, Dmitriy V. Cherkashin, Sergey L. Grishayev, Semen V. Efimov, Mikhail A. Kharitonov, Sayera A. Turdialieva, Гришаев Сергей Леонидович, Харитонов Михаил Анатольевич

    The early bronchodilatory effects of the first dose of long-acting anticholinergics (glycopyrronium and tiotropium) were compared with those of a fixed double combination of long-acting bronchodilators of various classes (indacaterol/glycopyrronium) in patients with stable chronic obstructive pulmonary disease. The possibility of using the results of an early bronchodilatory response to predict their effectiveness in the basic therapy of chronic obstructive pulmonary disease is evaluated. A total of 176 patients with chronic obstructive pulmonary disease were examined. The patients were randomized into three groups. The first group (n = 66) took glycopyrronium, the second group (n = 60) received a combination of indacaterol/glycopyrronium, and the third group (n = 50, control) took tiotropium. Broncholytic tests with the listed drugs were evaluated. The early bronchodilatory effect of the first dose of 110/50 mcg indacaterol/glycopyrronium was manifested by significant bronchodilation (p 0.001) from 30 min, reached its maximum value 60 min after drug intake, and persisted after a 28-day course of treatment. The combination of indacaterol/glycopyrronium provided rapid and prolonged bronchodilation in patients with stable chronic obstructive pulmonary disease, demonstrating advantages over the isolated use of glycopyrronium and tiotropium. Maximization of bronchodilation by the sequential use of glycopyrronium and salbutamol leads to an increase in the volume of forced exhalation in the first second on the 90th min, comparable with the results of indacaterol/glycopyrronium on the 60th min after drug intake, which indicates the clinical feasibility of maximizing bronchodilation with drugs both separately and in combination. Based on a direct positive correlation between the initial value of the forced expiratory volume in the first second and the value on day 28 of indacaterol/glycopyrronium therapy, an equation for predicting the individual effectiveness of the drug during treatment is derived.

  • Determination of peak inspirate flow for selection of the optimal inhalator in patients with chronic obstructive pulmonary disease non-exanction

    by N. V. Sharova, D. V. Cherkashin, A. D. Sobolev, I. A. Solov’ev

    Основным путем лечения ХОБЛ является ингаляционный. В клинике широкое распространение получили порошковые ингаляторы (ПИ), эффективность которых зависит от возможности пациента создавать адекватный пиковый инспираторный поток (ПИП). С помощью прибора In-Check DIAL™ G16 Clement Clarke International Limited установлено, что ограничение ПИП встречается при различных сопротивлениях прибора в 9,7-58 % случаев ХОБЛ вне обострения. Выбор ингалятора и обучение пациентов правильной технике ингаляции с учетом значений ПИП, замена ПИ дозированными аэрозольными или жидкостными ингаляторами - пути оптимизации ингаляционной...

  • Open Access

    Clinical case of eosinophilic granulomatous polyangiitis debuted by myocardial infarction

    by Evgeniy V. Kryukov, Dmitriy V. Cherkashin, Sergey L. Grishaev, Sayora A. Turdialieva, Elena A. Mozharovskaya, Natal’yA V. Sharova, Ol'GA M. Kudrina, Sergey L. Vorobyov, Крюков Евгений Владимирович, Воробьев Сергей Леонидович

    The article presents clinical observations demonstrating the difficulties of diagnostic search in establishing the diagnosis of systemic vasculitis associated with antineutrophil cytoplasmic antibodies, which include a rare disease eosinophilic granulomatosis with polyangiitis (ChurgStrauss syndrome). Carefully collected anamnesis, participation of specialists of different profiles, retrospective analysis of laboratory and instrumental data allowed to verify the diagnosis, to prescribe adequate therapy. The aim of the publication is to discuss the need for early diagnosis of eosinophilic granulomatosis with polyangiitis, which can improve the effectiveness of therapy and improve the overall prognosis for this disease, taking into account modern approaches based on the main provisions of international recommendations that were prepared in 2015 with the participation of leading experts from Europe, USA and Canada and were called to become the basis for choosing a personalized patient therapy strategy. In some cases, the diagnosis of eosinophilic granulomatous polyangiitis is complicated by the diversity of the clinical picture, the non-simultaneous appearance of the main symptoms and the violation of the stages of the process. In the differential diagnosis of systemic vasculitis, assessment of initial clinical manifestations, testing for the presence of antibodies to the cytoplasm of neutrophils, multispiral computed tomography of the chest organs and diagnostic biopsy of the affected tissues are crucial. In the histological conclusion, a picture of focal ulcerative-necrotic lesions of the nasal mucosa with signs of vasculitis and a pronounced eosinophilic cell component of inflammation was noted. The distinctive features of this case include the onset of the disease with the development of myocardial infarction and early damage to the hearing organ in the form of cochlear neuritis, complicated by sensorineural hypoacusis. The combination of high doses of glucocorticosteroids and cyclophosphamide is still the gold standard for the treatment of severe cases, but the use of biological agents such as rituximab or mepolizumab seems to be a promising therapeutic alternative (4 figs, bibliography: 3 refs).


  • Open Access

    Dyspnoea in General Medicine: Diaphragm Paresis in a Patient with Bronchial Asthma

    by N.V. Sharova, D.V. Cherkashin, R.G. Makiev, V.N. Goryutskiy, A.V. Potekhina, I.E. Sukhoroslova, Russian Federation St. Petersburg, Russian Federation Ministry Of Defense; St. Petersburg S.M. Kirov Military Medical Academy (A Federal Government-Funded Military Educational Institution Of Higher Education), Russian Federation Chief Army Medical Directorate At The Ministry Of Defence Of The Russian Federation; Moscow

    Objective of the Paper: To demonstrate peculiar properties of dyspnoea, challenges with diagnosis and functional contribution of herpetic (Herpes zoster) and post-traumatic diaphragm paresis (DP) to respiratory disorders in a patient with bronchial asthma (BA). Key Points. We described peculiar properties of dyspnoea in DP in a patient with BA. Functional contribution from DP was measured using spirometric methods: reduction in lung capacity and forced vital capacity by more than 35% when the patient body position became horizontal. Combined DP genesis caused incomplete recovery of phrenic nerve during follow-up. Conclusion. In unspecified dyspnoea, a GP should be vigilant and should check diaphragm function. In diagnosis of DP, X-ray, ultrasound and functional examinations are of utmost importance. Keywords: dyspnoea, diaphragm paresis, bronchial asthma, shingles.